AKAP5 Polyclonal Antibody
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0451514
- Awardee
- LIFE TECHNOLOGIES CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $384.00
About this award
Life Technologies Corporation was awarded contract A207_PO-0451514 by the University of Virginia on June 23, 2026, for the supply of laboratory reagents. The contract is valued at $384 and involves the delivery of one AKAP5 Polyclonal Antibody unit to Saainikedhana Venugopal at the University of Virginia. A-Kinase Anchoring Protein 5 (AKAP5) polyclonal antibodies are research-grade immunological reagents commonly utilized in biochemical and molecular biology applications.
The contract represents a straightforward procurement of a single laboratory product with a total cumulative value of $384. The award was executed through the University of Virginia's purchasing mechanism in the Commonwealth of Virginia. No information regarding an extended performance period is provided in the contract documentation, suggesting this represents a single-transaction supply order for immediate delivery of the specified antibody product.
Line items
| Item | Total |
|---|---|
| AKAP5 Polyclonal Antibody | $384.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0451514?
Contract A207_PO-0451514 was awarded to LIFE TECHNOLOGIES CORPORATION by University of Virginia on June 23, 2026.
How much is contract A207_PO-0451514 worth?
Its cumulative value is $384.00.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award